No name

Did you know that schizophrenia affects more than 1 percent of the world's population?

See NARSAD Grants at work on the latest schizophrenia research

Schizophrenia is a severe, chronic, and generally disabling brain and behavior disorder. It is most accurately described as a psychosis - a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be caused by a combination of genetic and environmental factors.

Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them. Negative symptoms may include avolition (a lack of desire or motivation to accomplish goals), lack of desire to form social relationships, and blunted affect and emotion. Cognitive symptoms involve problems with attention and memory, especially in planning and organization to achieve a goal. Cognitive deficits are the most disabling for patients trying to lead a normal life.

learn more about schizophrenia

Visit the Schizophrenia Research Forum, fully sponsored by the Brain & Behavior Research Foundation—a virtual community of scientists collaborating in their quest for causes, improved treatments, and better understanding of schizophrenia.

Visit the Schizophrenia Research Forum for more information about research

 

E. Jane Costello, Ph.D., expert on childhood and adolescent psychiatric illness, anxiety and depression
E. Jane Costello, Ph.D.
February 07, 2014
More than 20 years ago, E. Jane Costello, Ph.D., and collaborators at Duke University Medical Center initiated what has since proven to be one of the most...
Forbes.com Feature’s Top Research Discoveries by NARSAD Grantees in 2013
February 05, 2014
The Brain & Behavior Research Foundation announced the top 10 Discoveries of 2013 by NARSAD Grantees, which provide new insight into the mysteries of the...
February 04, 2014
Contact: Nadine Woloshin212-843-8041 / 917-699-9456nwoloshin@rubenstein.com For Immediate ReleaseTop Findings Decode Brain Mysteries with 3D and May Herald New...
Los Angeles Times Features Article about new depression treatments
February 04, 2014
According to the National Institute of Mental Health (NIMH), almost seven percent of the U.S. adult population is diagnosed with depression. Anyone with a...
Karl Deisseroth, M.D., Ph.D., expert on depression research and CLARITY and optogenetics
Karl Deisseroth, M.D., Ph.D.
February 03, 2014
Today, 2013 Brain & Behavior Research Foundation Goldman-Rakic Prizewinner for Outstanding Achievement in Cognitive Neuroscience, Karl Deisseroth, M.D., Ph...

Pages

Subscribe to